News Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Real-time Estimate Cboe Europe Other stock markets 03:50:44 2024-05-28 am EDT			5-day change	1st Jan Change
201.9 ^SEK	+77.73%		+74.31%	+59.09%

May. 24	HC Wainwright Cuts Calliditas Therapeutics Price Target to $45 From $50, Maintains Buy Rating	MT
May. 23	Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Calliditas Therapeutics Gets $1.1 Billion Takeover Bid From Asahi Kasei	03:18am	DJ
Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion	03:08am	RE
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation	02:31am	AQ
HC Wainwright Cuts Calliditas Therapeutics Price Target to $45 From $50, Maintains Buy Rating	May. 24	MT
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	May. 23	MT
Calliditas Therapeutics : May 23, 2024 Interim Report Q1 2024 (Presentation)	May. 23	PU
Transcript : Calliditas Therapeutics AB, Q1 2024 Earnings Call, May 23, 2024	May. 23
Calliditas Therapeutics AB Reaffirms Earnings Guidance for the Year Ending December 31, 2024	May. 23	CI
Calliditas Therapeutics : May 23, 2024 Interim Report Q1 2024 (Report)	May. 23	PU
Calliditas Q1 report, January - March 2024	May. 23	AQ
Calliditas Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23	CI
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	May. 21	MT
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	May. 20	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	May. 16	MT
In Person & Virtual R&D Day: The Anti Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action	May. 16	PU
In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action	May. 16	AQ
Calliditas Therapeutics : Invitation to the presentation of Calliditas´s interim report January - March 2024	May. 16	PU
Invitation to the presentation of Calliditas's interim report January - March 2024	May. 16	AQ
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading	May. 15	MT
Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm	May. 15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Summary

Filters